NVE Corp: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Oct 18, 2023 and accepted by EDGAR at Oct 18, 2023, 16:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $7.1m | us-gaap:Revenues |
| Revenue | 6 months2023-04-01 to 2023-09-30 | $16.0m | us-gaap:Revenues |
| Cost of revenue | 3 months2023-07-01 to 2023-09-30 | $1.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-04-01 to 2023-09-30 | $3.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-07-01 to 2023-09-30 | $5.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-04-01 to 2023-09-30 | $12.3m | us-gaap:GrossProfit |
| Research and development | 3 months2023-07-01 to 2023-09-30 | $683.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-04-01 to 2023-09-30 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-07-01 to 2023-09-30 | $4.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-04-01 to 2023-09-30 | $10.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-07-01 to 2023-09-30 | $407.9k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-04-01 to 2023-09-30 | $1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | $4.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-04-01 to 2023-09-30 | $9.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-01 to 2023-09-30 | $0.98 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-04-01 to 2023-09-30 | $1.89 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-01 to 2023-09-30 | $0.98 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-04-01 to 2023-09-30 | $1.89 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 4,840,770 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-04-01 to 2023-09-30 | 4,840,688 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-04-01 to 2023-09-30 | $10.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-04-01 to 2023-09-30 | $16.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-04-01 to 2023-09-30 | $9.7m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2023-09-30 | $7.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $25.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $67.7m | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $961.3k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-30 | $1.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-09-30 | $66.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001753926-23-001369. Last ingested by Listed: Nov 5, 2026, 19:10 ET. Listed shows no prices and gives no investment advice.